Ovarian epithelial cancer stage III

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
PARP inhibitor 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Mario Negri Institute For Pharmacological Research Academic
    OLAPARIB
    2022-502242-27-00 1 country 2023 n=190
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Mario Negri Institute For Pharmacological Research Academic 1 Phase IV 0
New trials by year
2023
1
← All indication landscapes